Our first product is designed for mammalian cell proliferation. Optimised performance across multiple cell lines (universibility) similar to FBS using proprietary ingredients.
Designed for large-scale industrial usage from the ground up.
Risk of contaminants (viruses, immunogens or hemoglobins) are avoided by design. Safe for food production.
We are looking to ship out test samples to selected partners for trial in Q2 2021 and start wide-scale production in the second half of 2021.